Supernus Pharmaceuticals | SUPN - Ebit

Prix De L'Action
50.57
Variation Quotidienne
0.36 0.72%
Mensuellement
-2.03%
Annuel
57.25%
Q1 Prévisions
48.40




Ebit Changement Date
Abbott USD 2.54B 358M 2025-12
ANI Pharmaceuticals USD 29.13M 6.3M 2025-12
Aurora Cannabis CAD -44.75M 27.14M 2025-09
Bristol-Myers Squibb USD 3.47B 567M 2025-12
Canopy Growth CAD -14.3M 17.19M 2025-09
Cara Therapeutics USD -2.39M 3.16M 2025-03
Corcept Therapeutics USD 4.49M 5.73M 2025-12
Eisai JPY 20.03B 6.36B 2025-12
Eli Lilly USD 8.99B 1.57B 2025-12
Novo Nordisk DKK 32.38B 1.7B 2025-12
Pacira USD 3.19M 9.96M 2025-12
Perrigo USD 84.4M 9M 2025-12
Pfizer USD 4.65B 71M 2025-12
Supernus Pharmaceuticals USD 13.82M 74.01M 2025-12
United Therapeutics USD -14.6M 403.9M 2025-12
Xeris Pharmaceuticals USD 7.89M 2.46M 2025-09